81 related articles for article (PubMed ID: 19026137)
1. CTLA-4 gene variants are not associated with Behçet's disease or its clinical manifestations.
Touma Z; Hamdan A; Shamseddeen W; Nasr J; Makhoul N; Zalloua PA; Arayssi T
Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S132. PubMed ID: 19026137
[No Abstract] [Full Text] [Related]
2. Cytotoxic T lymphocyte antigen-4 (CTLA-4) polymorphism in patients with Behçet's disease.
Düzgün N; Duman T; Keskin O; Morris Y; Tutkak H
Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S100. PubMed ID: 20868585
[No Abstract] [Full Text] [Related]
3. TNF polymorphisms in Lebanese patients with Behçet's disease.
Arayssi TK; Hamdan AR; Touma Z; Shamseddeen W; Uthman IW; Hourani HB; Farra CG
Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S130-1. PubMed ID: 19026135
[No Abstract] [Full Text] [Related]
4. CTLA-4 +49A/G polymorphism is associated with Behçet's disease in a Tunisian population.
Ben Dhifallah I; Chelbi H; Braham A; Hamzaoui K; Houman MH
Tissue Antigens; 2009 Mar; 73(3):213-7. PubMed ID: 19254250
[TBL] [Abstract][Full Text] [Related]
5. Analysis of CD28 and CTLA-4 gene polymorphisms in Turkish patients with Behcet's disease.
Gunesacar R; Erken E; Bozkurt B; Ozer HT; Dinkci S; Erken EG; Ozbalkan Z
Int J Immunogenet; 2007 Feb; 34(1):45-9. PubMed ID: 17284227
[TBL] [Abstract][Full Text] [Related]
6. No association of CTLA-4 polymorphisms with susceptibility to Behçet disease.
Du L; Yang P; Hou S; Zhou H; Kijlstra A
Br J Ophthalmol; 2009 Oct; 93(10):1378-81. PubMed ID: 19570770
[TBL] [Abstract][Full Text] [Related]
7. CTLA-4 polymorphisms are not associated with ocular inflammatory disease.
Bye L; Modi N; Stanford MR; Kondeatis E; Vaughan R; Fortune F; Kanawati C; Ben-Chetrit E; Ghabra M; Murray PI; Wallace GR
Tissue Antigens; 2008 Jul; 72(1):49-53. PubMed ID: 18498289
[TBL] [Abstract][Full Text] [Related]
8. Haplotypes of the endothelial protein C receptor gene and Behçet's disease.
Navarro S; Bonet E; Medina P; Martos L; Ricart JM; Vayá A; Todolí J; Fontcuberta J; Estellés A; España F
Thromb Res; 2012 Apr; 129(4):459-64. PubMed ID: 21851971
[TBL] [Abstract][Full Text] [Related]
9. CTLA-4 gene 49A/G polymorphism in Turkish patients with Behçet's disease.
Sallakci N; Bacanli A; Coskun M; Yavuzer U; Alpsoy E; Yegin O
Clin Exp Dermatol; 2005 Sep; 30(5):546-50. PubMed ID: 16045690
[TBL] [Abstract][Full Text] [Related]
10. The role of CTLA-4 exon-1 49 A/G polymorphism and soluble CTLA-4 protein level in egyptian patients with Behçet's disease.
Abdel Galil SM; Hagrass HA
Biomed Res Int; 2014; 2014():513915. PubMed ID: 24991555
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) in isolated vitiligo: a genotype-phenotype correlation.
Dwivedi M; Laddha NC; Imran M; Shah BJ; Begum R
Pigment Cell Melanoma Res; 2011 Aug; 24(4):737-40. PubMed ID: 21794098
[No Abstract] [Full Text] [Related]
12. Association of mitochondrial polymorphism m.709G>A with Behçet's disease.
Xavier JM; Shafiee NM; Ghaderi F; Rosa A; Abdollahi BS; Nadji A; Shahram F; Davatchi F; Oliveira SA
Ann Rheum Dis; 2011 Aug; 70(8):1514-6. PubMed ID: 21345811
[No Abstract] [Full Text] [Related]
13. Mevalonate kinase gene mutations and their clinical correlations in Behçet's disease.
Arslan Taş D; Erken E; Yildiz F; Dinkçi S; Sakalli H
Int J Rheum Dis; 2014 May; 17(4):435-43. PubMed ID: 24411001
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel genetic susceptibility loci for Behçet's disease using a genome-wide association study.
Fei Y; Webb R; Cobb BL; Direskeneli H; Saruhan-Direskeneli G; Sawalha AH
Arthritis Res Ther; 2009; 11(3):R66. PubMed ID: 19442274
[TBL] [Abstract][Full Text] [Related]
15. No association of granzyme B gene polymorphism with Behçet's disease.
Kucuksezer UC; Duymaz-Tozkir J; Gül A; Saruhan-Direskeneli G
Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S102. PubMed ID: 19796544
[No Abstract] [Full Text] [Related]
16. Tumour necrosis factor-alpha gene promoter region -308 and -376 G-->A polymorphisms in Behçet's disease.
Duymaz-Tozkir J; Gül A; Uyar FA; Ozbek U; Saruhan-Direskeneli G
Clin Exp Rheumatol; 2003; 21(4 Suppl 30):S15-8. PubMed ID: 14727453
[TBL] [Abstract][Full Text] [Related]
17. Association of a CTLA-4 3' untranslated region (CT60) single nucleotide polymorphism with autoimmune thyroid disease in the Japanese population.
Ban Y; Tozaki T; Taniyama M; Tomita M; Ban Y
Autoimmunity; 2005 Mar; 38(2):151-3. PubMed ID: 16040335
[TBL] [Abstract][Full Text] [Related]
18. Increased risk of human leukocyte antigen-G gene variants in Behçet's disease.
Park KS; Nam JH; Lee ES; Choi JS; Bang D; Lee S
Clin Exp Rheumatol; 2006; 24(5 Suppl 42):S126-7. PubMed ID: 17067446
[No Abstract] [Full Text] [Related]
19. Evaluation of leptin level and Ob gene polymorphism in patients with Behcet's disease.
Okudan N; Acar H; Gökbel H; Mevlitoğlu I; Sari F
Arch Dermatol Res; 2006 Aug; 298(3):127-30. PubMed ID: 16786343
[TBL] [Abstract][Full Text] [Related]
20. Lack of association between CTLA-4 +49A/G and -318C/T polymorphisms and Behçet's disease risk: a meta-analysis.
Zhang YJ; Xu WD; Duan ZH; Liu SS; Pan HF; Ye DQ
Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S46-50. PubMed ID: 23010350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
